Medical device licence · 96831 · Class 2
IMMUNOTROL
No longer licensed: discontinued at renewal
Licence status Discontinued at renewal; first licensed April 12, 2016; ended December 11, 2018. It is in Health Canada’s archive of licences no longer in force.
- Licence number
- 96831
- Licence holder
- Theradiag SaCroissy Beaubourg, France
- Risk class
- Class II (low to moderate risk)
- Licence type
- Device Family
- First licensed
- April 12, 2016
- Ended
- December 11, 2018
- Devices covered
- 4
Devices on this licence
By name, as listed. The official record lists model numbers and identifiers.
- IMMUNOTROL ADALIMUMAB
- IMMUNOTROL ANTI-ADALIMUMAB
- IMMUNOTROL ANTI-INFLIXIMAB
- IMMUNOTROL INFLIXIMAB
Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.